抗艾药品绥美凯的价格

(TRIUMEQ) is the first single-tablet compound preparation with a complete treatment plan in the field of HIV treatment in mainland China; it is suitable for the treatment of adults and adolescents over 12 years old (with a weight of at least 40kg) infected with human immunodeficiency virus (HIV).

Triumeq (TRIUMEQ) has been approved in more than 100 countries and recommended by many authoritative academic institutions in Europe and the United States as a first-line treatment drug for newly treated AIDS patients. Through effective treatment, the life spans of AIDS patients and healthy people are getting closer and closer. Medication compliance and convenience of medication play an increasingly important role in further improving patients' quality of life. The approval of Triumeq (TRIUMEQ) has filled the gap in AIDS and met the urgent need for convenient medication for doctors and patients.

How much does the anti-AIDS drug Suimeika cost?

It is understood that TRIUMEQ (TRIUMEQ) produced by Emcure in India is cost-effective, with a specification of 30 tablets and a price of about $1,000. Since the exchange rate is floating and the price is not fixed, if patients want to know the specific price information of the drug, they can consult the medical companion travel service.

Taking TRIUMEQ (TRIUMEQ) for treatment will also produce certain side effects or adverse reactions, including: nausea/insomnia/dizziness/headache, etc. Before receiving this drug for treatment, patients must go to the hospital for a detailed examination and take the drug according to the doctor's diagnosis and treatment recommendations.

Patients with abacavir hypersensitivity often experience nausea/vomiting/diarrhoea/fever/drowsiness/rash and other symptoms when using abacavir (TRIUMEQ). If patients experience these symptoms, they should be carefully evaluated for the presence of such a hypersensitivity reaction. Very rarely, erythema multiforme, Stevens-Johnson syndrome, or toxic epidermal necrolysis may occur, and abacavir hypersensitivity cannot be excluded. In such cases, abacavir-containing medicinal products should be permanently discontinued. In individual patients, hypersensitivity reactions, including rash and severe hepatic effects, may occur.

Recommended related hot articles: /newsDetail/80706.html